+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Viral Hepatitis and Retrovirus Diagnostic Tests - Global Strategic Business Report

  • PDF Icon

    Report

  • 168 Pages
  • April 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140113
The global market for Viral Hepatitis and Retrovirus Diagnostic Tests was valued at US$4.8 Billion in 2024 and is projected to reach US$7.7 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Viral Hepatitis and Retrovirus Diagnostic Tests market.

Global Viral Hepatitis and Retrovirus Diagnostic Tests Market - Key Trends & Drivers Summarized

Why Is Early and Accurate Diagnosis Critical for Viral Hepatitis and Retroviral Infections?

The burden of viral hepatitis and retroviral infections continues to rise globally, driving an urgent need for early and precise diagnostic solutions. With hepatitis B and C responsible for millions of chronic infections and a leading cause of liver cancer, governments and healthcare agencies are ramping up screening efforts to control disease progression. Similarly, human immunodeficiency virus (HIV) infections remain a significant global health challenge, necessitating routine and high-sensitivity diagnostic tests. The adoption of polymerase chain reaction (PCR)-based tests and next-generation sequencing (NGS) technologies has revolutionized the accuracy of virus detection, enabling healthcare providers to diagnose infections at an early stage. Additionally, the rise of rapid antigen-based and point-of-care (POC) testing solutions is expanding access to timely diagnosis, particularly in low-resource settings where centralized laboratory infrastructure is limited.

How Is Technology Reshaping Viral Diagnostic Testing?

Technological advancements are playing a pivotal role in transforming viral hepatitis and retrovirus diagnostics. The integration of artificial intelligence (AI) and machine learning into diagnostic platforms is improving test accuracy and predictive analytics, facilitating early intervention and disease management. Automated, multiplexed testing platforms capable of detecting multiple viral strains in a single assay are gaining traction in clinical settings, reducing diagnostic turnaround times and streamlining patient management. Additionally, the development of portable molecular diagnostic devices is addressing the growing need for decentralized testing, enabling real-time viral load monitoring in remote and rural areas. The adoption of microfluidics and lab-on-a-chip technologies is also improving diagnostic efficiency, ensuring minimal sample volume requirements and rapid detection capabilities.

What Market Dynamics Are Driving Adoption of Advanced Diagnostic Solutions?

A surge in government-led screening initiatives and universal healthcare coverage programs is expanding the adoption of viral hepatitis and retrovirus diagnostic tests. Countries with high endemicity, particularly in Asia-Pacific and sub-Saharan Africa, are investing heavily in national screening programs to curb transmission rates and enhance patient outcomes. The increasing emphasis on home-based self-testing solutions is also reshaping the market, particularly in HIV diagnostics, where confidential and convenient testing is gaining acceptance. Furthermore, the growing prevalence of co-infections, such as hepatitis C and HIV, is driving demand for combined diagnostic assays, allowing for comprehensive patient management. The rapid expansion of telemedicine and digital health solutions is further strengthening the diagnostic landscape by integrating remote testing capabilities and digital result reporting.

The growth in the viral hepatitis and retrovirus diagnostic tests market is driven by several factors, including the rising global disease burden, technological advancements in diagnostic methodologies, and increasing government support for large-scale screening programs. The expansion of molecular and point-of-care diagnostics is enabling faster, more accurate, and more accessible testing, particularly in underserved regions. The shift towards AI-driven diagnostics and digital health platforms is further enhancing market dynamics, improving efficiency in disease detection and patient management. Additionally, growing investments in research and development (R&D) are leading to innovations in highly sensitive, multiplexed, and portable testing solutions, catering to evolving healthcare needs. The increasing demand for early-stage diagnostics to prevent long-term complications and improve treatment outcomes is expected to sustain market growth in the coming years.

Report Scope

The report analyzes the Viral Hepatitis and Retrovirus Diagnostic Tests market, presented in terms of units. The analysis covers the key segments and geographic regions outlined below.

Segments: Segment (Viral Hepatitis & Retrovirus Diagnostic Tests).

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Regional Analysis

Gain insights into the U.S. market, valued at $1.2 Billion in 2024, and China, forecasted to grow at an impressive 11.3% CAGR to reach $1.7 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Viral Hepatitis and Retrovirus Diagnostic Tests Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Viral Hepatitis and Retrovirus Diagnostic Tests Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Viral Hepatitis and Retrovirus Diagnostic Tests Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abbott Diagnostics, Amkay Products, AOV International, Apothecaries Sundries Manufacturing, BD and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 31 companies featured in this Viral Hepatitis and Retrovirus Diagnostic Tests market report include:

  • Abbott Diagnostics
  • Amkay Products
  • AOV International
  • Apothecaries Sundries Manufacturing
  • BD
  • Beckman Coulter
  • Bhat Bio-tech
  • BioMerieux
  • Bioneovan
  • Bio-Rad
  • Cepheid
  • Chembio
  • DiaSorin
  • Enzo Biochem
  • Fujirebio
  • Gemc Technology
  • Grifols
  • Hangzhou Deangel Biological Engineering
  • Hangzhou Heo Bio-Tech
  • Hologic
  • Horiba
  • Innovation Biotech
  • Jaksh Enterprises
  • Krishco Medical Products
  • Roche Diagnostics

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

  • Tariff-adjusted market forecasts by region and segment
  • Analysis of cost and supply chain implications by sourcing and trade exposure
  • Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

  • Finalized tariff impacts and new trade agreement effects
  • Updated projections reflecting global sourcing and cost shifts
  • Expanded country-specific coverage across the industry

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Viral Hepatitis and Retrovirus Diagnostic Tests - Global Key Competitors Percentage Market Share in 2024 (E)
  • Global Economic Update
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Growing Global Burden of Hepatitis and Retroviral Infections Driving Demand for Early Diagnostic Solutions
  • Increasing Adoption of Point-of-Care and Rapid Diagnostic Tests Enhancing Market Growth
  • Rising Integration of AI and Machine Learning in Viral Diagnostic Testing Improving Accuracy and Efficiency
  • Expansion of Universal Screening Programs Boosting Market Penetration of Hepatitis & Retrovirus Diagnostics
  • Growing Preference for Multiplex Testing Platforms Enhancing Market Demand for Comprehensive Assays
  • Advances in Next-Generation Sequencing (NGS) Improving Viral Genotyping and Personalized Treatment Strategies
  • Increasing Availability of Home-Based and Self-Testing Kits Enhancing Accessibility and Market Adoption
  • Collaborations Between Diagnostic Companies and Public Health Organizations Driving Market Expansion
  • Growing Adoption of Microfluidics and Lab-on-a-Chip Technologies Revolutionizing Viral Diagnostics
  • Rising Investments in Healthcare Infrastructure in Emerging Markets Fueling Diagnostic Test Uptake
  • Development of High-Sensitivity and Early Detection Assays Creating New Revenue Streams
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 2: World Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 3: World 15-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • Table 4: World Viral Hepatitis and Retrovirus Diagnostic Tests Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • Table 5: USA Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 6: USA Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
CANADA
  • Table 7: Canada Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 8: Canada Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
JAPAN
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • Table 9: Japan Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 10: Japan Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
CHINA
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • Table 11: China Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 12: China Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
EUROPE
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • Table 13: Europe Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 14: Europe Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 15: Europe 15-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
FRANCE
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • Table 16: France Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 17: France Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
GERMANY
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • Table 18: Germany Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 19: Germany Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
ITALY
  • Table 20: Italy Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 21: Italy Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
UNITED KINGDOM
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • Table 22: UK Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 23: UK Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
SPAIN
  • Table 24: Spain Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 25: Spain Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
RUSSIA
  • Table 26: Russia Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 27: Russia Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
REST OF EUROPE
  • Table 28: Rest of Europe Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 29: Rest of Europe Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
ASIA-PACIFIC
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • Table 30: Asia-Pacific Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 31: Asia-Pacific Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 32: Asia-Pacific 15-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
AUSTRALIA
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • Table 33: Australia Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 34: Australia Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
INDIA
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • Table 35: India Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 36: India Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
SOUTH KOREA
  • Table 37: South Korea Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 38: South Korea Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
REST OF ASIA-PACIFIC
  • Table 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 40: Rest of Asia-Pacific Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
LATIN AMERICA
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • Table 41: Latin America Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 42: Latin America Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 43: Latin America 15-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
ARGENTINA
  • Table 44: Argentina Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 45: Argentina Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
BRAZIL
  • Table 46: Brazil Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 47: Brazil Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
MEXICO
  • Table 48: Mexico Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 49: Mexico Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
REST OF LATIN AMERICA
  • Table 50: Rest of Latin America Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 51: Rest of Latin America Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
MIDDLE EAST
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • Table 52: Middle East Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 53: Middle East Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 54: Middle East 15-Year Perspective for Viral Hepatitis and Retrovirus Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
IRAN
  • Table 55: Iran Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 56: Iran Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
ISRAEL
  • Table 57: Israel Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 58: Israel Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
SAUDI ARABIA
  • Table 59: Saudi Arabia Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 60: Saudi Arabia Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
UNITED ARAB EMIRATES
  • Table 61: UAE Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 62: UAE Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
REST OF MIDDLE EAST
  • Table 63: Rest of Middle East Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 64: Rest of Middle East Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
AFRICA
  • Viral Hepatitis and Retrovirus Diagnostic Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • Table 65: Africa Recent Past, Current & Future Analysis for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 66: Africa Historic Review for Viral Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Diagnostics
  • Amkay Products
  • AOV International
  • Apothecaries Sundries Manufacturing
  • BD
  • Beckman Coulter
  • Bhat Bio-tech
  • BioMerieux
  • Bioneovan
  • Bio-Rad
  • Cepheid
  • Chembio
  • DiaSorin
  • Enzo Biochem
  • Fujirebio
  • Gemc Technology
  • Grifols
  • Hangzhou Deangel Biological Engineering
  • Hangzhou Heo Bio-Tech
  • Hologic
  • Horiba
  • Innovation Biotech
  • Jaksh Enterprises
  • Krishco Medical Products
  • Roche Diagnostics

Table Information